Immunization. Mice were immunized intraperitoneatly with 150 #g NP-KLH in a 0.2-ml mixture containing 25% pertussis vaccine (Michigan Dept. of Public Health, Lansing, Mich.).
Haptenated Cell Preparation. NP-coupled spleen cells were made as described previously (17) .
Cells were washed extensively in minimum essential medium (MEM) before intravenous injection of 3 X 107 NP-eoupled cells into syngeneic recipients.
In Vitro Subcultures. Spleen cells from control mice or mice treated 7 d earlier with NPcoupled spleen cells were teased and washed under sterile conditions. These cells were added to Linbro culture wells (Flow Laboratories, Inc., Hamden, Conn.) at a concentration of 7.5 × 106 cells/ml/well in Mishell-Dutton culture medium containing 10% fetal calf serum, (FCS; lot 95045, Microbiological Associates, Walkersville, Md.). (2ultures were incubated at 37°(2 in a 10% (202 atmosphere in rocking culture boxes and fed daily with 0.1 ml supplementary medium for a 4-d subculture period. Cells were then pooled, washed, and 5 X 105 viable normal or suppressor cells were added to 7.5 × 108 NP~primed cells.
Purification of T Cells and Fractionation of NP Idiotype-binding Cells. The method of Mage et al.
(21) was used to purify splenic T cells from subculture. Purified rabbit anti-mouse immunoglobulin (RAMIg; 5 mi of a 1 mg/ml solution) was added to 100-× 15-mm polystyrene petri plates (1005; Falcon Plastics, Div. of Becton, Dickinson & Co., Oxnard, Calif.) and incubated for 1 h at room temperature. Unbound antibody was washed off and 8 × 107 viable cells from subcultures were added for a 1-h incubation period at 20°(2. The nonadherent T cell population was recovered by gentle swirling. Less than 1.0% of these cells stained with a fluorescent RAMIg antiserum. Idiotype-specifie suppressor cells were separated according to the method of Abbas et al. (22) . Anti-NP antiserum was prepared by immunization of C57BL/6 (Igh-1 b) or C3H.NB (Igh-1 j) mice with 100 #g NP-BGG in pertussis vaccine and specific antibody was obtained by affinity purification. 5 ml of a 1 mg/ml solution of purified anti-NP antibodies from C57BL/6 (Igh-1 °) or (23H.NB (Igh-1 j) mice were incubated on 100-× 15-mm polystyrene petri dishes for 1 h at room temperature. After removal of immunoglobulin solutions, the plates were washed as above. 10 × 106-15 × 106 purified suppressor T cells were added to each plate in a total volume of 5 ml MEM containing 5% F(2S. (2ells were incubated for 1 h at room temperature. Nonadherent cells were removed and the dishes were washed extensively with warm (20°C) media. After addition of 5.0 ml cold media, the dishes were incubated on ice for 30 min. Adherent cells were resuspended with vigorous pipetting, washed, and counted. In Vitro Responder Cultures. C57BL/6 mice were immunized intraperitoneally with 150 pg NP-KLH with 25% pertussis vaccine. 4 wk later, their spleens were removed and teased into a single cell suspension under sterile conditions. Cells were washed and resuspended in MishellDutton media containing 10% FCS. 7.5 × 106 viable NP-primed cells was added to each well of Linbro culture plates. Cultures were challenged with 100 ng NP-GI~ or NP-Ficoll in 20 pl. A primary sheep erythrocyte (SRBC) response was obtained by addition of 2 × 106 washed SRBC to culture wells containing 7.5 × 106 normal, unprimed spleen cells. All cultures were incubated in rocking boxes at 37°C in a 10% CO2 atmosphere and were fed daily with 0.1 ml supplementary medium. 4 d after challenge, subcultured control or suppressor cells were added. 5 d after challenge, duplicate wells were pooled and assayed for total NP-or SRBC-specific plaque-forming cell (PFC) responses in replicate slides.
PFC Assay. NP-or SRBC-specific PFC were assayed as reported previously (17) . NP bbearing B cells were inhibited from forming plaques by the addition of 3.0-4.0 ~1 anti-idiotypic reagent to each slide at the beginning of the assay. The control response was determined by addition of 3.0-4.0 #1 normal guinea pig gammaglobulin. The percent inhibition of PFC was calculated according to the formula: experimental PFC~ Percentage of inhibition = 1 -control PFC ,/ × 100. Table II . Purified suppressor T cells mediate this immune suppression because RAMIg nonadherent subcultured cells from NP-tolerized donors suppress the effector-phase immune response (Table II) . In addition, these suppressor T cells bound to NP b idiotype-coated plates because as few as 1 × 105-3 × 105 idiotype adherent cells suppressed the NP response 46-100% in the effector phase, whereas the idiotype nonadherent fraction was completely depleted of suppressor activity. That the suppressor cells did not recognize NP hapten potentially bound by the purified antibody was demonsirated by the inability of cells adherent to plates coated with C3H.NB anti-NP antibody to affect the response. As expected, all of the suppressive activity was found in the C3H.NB anti-NP antibody-coated plate nonadherent fraction. Furthermore, in two experiments (data not shown) suppressor cells failed to bind to NP-bovine serum albumin-coated petri dishes. The results indicate that subcultured cells from NP-modified spleen-cell-treated donors were T cells that specifically recognized NP b idiotypic determinants and did not directly function by an antigen-bridging mechanism.
Igh Homology Is Required to Transfer Suppression In Vitro. Recent reports have indicated
that suppressor cells transferred to normal recipients must be homologous with the recipient at the Igh locus (24) (25) (26) . Because the NP suppressor cells described above are idiotype specific, and because the gene that controls NP b idiotype is linked to the Igh-1 b locus (27, 28) , it would be expected that these suppressor cells would fail to Table  III . Suppressor cells from both CKB and C3H mice were effective in reducing the response of syngeneic responder cells in the effector phase by 54-89%. However, neither suppressor population was capable of diminishing the response of Igh mismatched responders. Thus, CKB suppressor cells suppressed CKB but not C3H responder cultures and vice versa. Effector-phase suppressor, therefore, must be homologous with the responder population at the Igh locus for expression of immune suppression. Table IV . Whereas treatment with anti-Lyt-1 antibody did not affect suppression, treatment with antiLyt-2 completely ablated the ability of suppressor populations to reduce an immune response in the effector phase. Thus, effeetor-phase T suppressor cells obtained after subculture of cells from hapten-modified spleen-cell-treated donors bear Lyt-2 determinants. Table V . Effector-phase, subcultured suppressor cells did not affect the ability of cultures of normal cells to respond to SRBC. In addition, in cultures in which both the NP-and SRBC-specific responses could be assayed simultaneously, subcultured cells that suppressed the NP-specific response 56% in the effector phase failed to significantly affect the SRBC-specific response. Thus, in these in vitro experiments, effector-phase suppressors did not appear to be capable of nonspecifically affecting the primary response to an unrelated particulate antigen even when specifically stimulated by an ongoing, NP-specific immune response.
Presence of Lyt-2 Determinants on
Effector-Phase T Suppressor Cells. To further characterize the effector-phase suppressor cell, its Lyt phenotype was determined. Suppressor cells obtained from subcultures were treated with monoclonal, ABA-conjugated antiLyt-1 or anti-Lyt-2 antibodies, followed by a rabbit anti-ABA antiserum plus C. 1.8 or 3.5 × 105 viable control or treated suppressor cells were added to responder cultures challenged 4 d earlier. 1 d later, cultures were assayed for NP-specific PFC responses. The results from a representative experiment are presented in
Specificity of Effector-Phase Suppressor

Discussion
In the present report, the ability of suppressor cells induced by the intravenous injection of NP-modified syngeneic spleen cells to affect the in vitro Npb-idiotypic PFC response was studied. Previously, it had been shown that the intravenous injection of NP-modified syngeneic cells induced at least two subsets of T cells capable of suppressing delayed-type hypersensitivity (DTH) and cutaneous sensitivity responses in vivo (6, 23, 24, 26) . One subset, termed induction-phase suppressor cells, bound to NP and was capable of specifically reducing a DTH response when given at the time of antigen priming. The second subset, referred to as effector-phase suppressor cells, adhered to NP b idiotype and was shown to be capable of suppressing the DTH response when given 5 d after antigen priming, i.e., at the time of antigen challenge. Furthermore, it appeared that these subsets were causally related because injection of induction-phase suppressor cells with antigen induced effector-phase suppressor cells. An extension of this system demonstrated that spleen cells from mice given an intravenous injection of NP-conjugated syngeneic spleen cells were capable of suppressing the NP b idiotype fraction of a PFC response either when transferred to normal syngeneic recipients or when subcultured for a 4-d period and then added to NP-KLH-primed responder cultures (17) . In those initial in vitro experiments, subcultured suppressor cells were added to responder cultures at the time of antigenic challenge. Given the idiotype specificity of subcultured suppressor cells from NPspleen-cell-treated donors, it appeared that these cells corresponded to the effectorphase, idiotype-specific DTH suppressor cells previously described (6) . Based on this hypothesis, it was predicted that this population of cells would suppress an ongoing immune response in an idiotype-specific fashion. Therefore, in the present experiments, suppressor cells were added to in vitro cultures several days after antigenic challenge. The ability of these cells to suppress an ongoing immune response during the efferent phase defined them as effector-phase suppressor cells. Because effectorphase suppressor cells were functional within a short period of time, it was likely that these cells represented a relatively mature population(s) of lymphoid cells. The maturational events required for differentiation to effector-phase suppressor cells appeared to take place during the 4-d subculture because spleen cells from donor mice treated 7 d earlier with NP-modified syngeneic cells were unable to suppress an in vitro response when added directly to responder cultures (data not shown). Furthermore, the ability of these cells to suppress an effector-phase response suggested that they correspond to second order suppressor cells (Ts2 or Ts ~) described in other systems (1-3, 6 ).
The detection of the Lyt-2 determinant on effector-phase suppressor cells in the NP system was consistent with results obtained in other systems (31, 32). Thus, cells capable of effecting immune suppression in several systems were lysed by treatment with anti-Lyt-2 antiserum plus C but not by anti-Lyt 1 plus C (1, 26, 33) . It is unlikely that this Lyt-2 +, T suppressor cell is a cytotoxic T lymphocyte because the NP-spleen cell-induced, effector-phase suppressor cell described in this (data not shown) and the related contact sensitivity system bears I-J region-encoded determinants that are thought to be absent on cytolytic T cells (26) . Furthermore, the suppressor cells described in this report fail to kill Npb-bearing hybridoma cell lines.
Effector-phase suppression appeared to be NP specific because subcultured NPinduced suppressor cells failed to alter the in vitro response to SRBC, even in the presence of the NP determinant. Evidence provided by both in vivo and in vitro studies suggested that suppression occurred at the B cell level. Thus, the response to NP-Ficoll, a relatively T-independent antigen (17, 34) , was decreased by the addition of NP-induced suppressor cells in vitro. In addition, the magnitude of the NP-specific response to NP-poly-(L-GIu54-L-Lysa6-L-AIa 1°) in vivo was significantly decreased despite the presence of poly-(L-Glu~-L-Lys36-L-Alal°)-specific T helper cell activity (17) .
The fine specificity of effector-phase suppression was determined by the measurement of suppression of idiotype-bearing B cell clones. For this purpose, a guinea pig antiserum was raised against purified anti-NP antibodies from C57BL/6 mice. This reagent was able to inhibit NP-specific plaque formation only in mice of the Igh-1 b allotype (17) . With this reagent, it was possible to demonstrate that effector-phase suppressor T cells specifically affected the expression of idiotype-positive B cells either in vivo or in vitro. That is, idiotype-negative clones were not suppressed even in the face of active suppression of idiotype-positive cells. In fact, the suppression of NP bbearing clones in vitro appeared in some experiments to allow the expression of previously undetected NP b negative B cells (Table I) The requirement for recognition of idiotypic determinants by effector-phase suppressor cells was further substantiated by their inability to function across an Igh allotype barrier. Thus, the absence of a homologous idiotype in Igh-mismatched recipients of effector-phase suppressor cells precluded recognition of target cells and thereby inhibited suppressor function. Similar findings have been reported in other systems in which interaction of T cell subsets was required for manifestation of immune suppression (4, (24) (25) (26) . The ability of suppressor cells induced in C3H/HeJ mice to suppress the ongoing response of syngeneic responder cells in vitro suggested either that a relatively homogeneous suppressor population recognized a predominant idiotype (NP i) common to all C3H mice or that the suppressor cell population was heterogeneous and recognized a series of idiotypes common only to that strain.
Although the effector-phase suppressor T cell described in this work recognized molecules bearing the NP b idiotype determinant and the overall effect of the suppression was the specific inhibition of idiotype-bearing B cells, there is, to date, no direct evidence proving that the effector-phase suppressor cell was in fact the final effector cell in the suppressor pathway. Thus, it is possible that the Lyt-2 + effectorphase T cell induced by subculture of spleen cells from NP-syngeneic cell-treated donors was merely an intermediary that interacted with and stimulated the final cell in the suppressor circuit whose direct target was the NP b idiotype-bearing B cell. Results obtained in other systems have suggested that a "T auxiliary" or Ts~ cell present in antigen primed populations was required for effector-phase (i.e., idiotypespecific) T suppressor cells to express their suppressive function (26, 35) . Experiments designed to elucidate this suppressor pathway further are currently underway.
In this report we have described a system in which idiotype-specific, effector-phase suppressor T cells were induced with antigen-modified syngeneic spleen cells. This study departed in that regard from other investigations in which idiotype-reactive T cells were generated by injection of idiotypic or anti-idiotypic antibodies (10, 11, 15, (18) (19) (20) . Although induction of T cell suppressor circuits with these antibodies is possible, induction of regulatory T cells with antigen probably reflects the physiologic role of these cells more accurately. The study of such a hapten-induced suppressor cell circuit will help clarify the nature of cellular interactions required to regulate the immune response to foreign antigens or to self antigens presented in the context of self cell surface determinants. It is important to emphasize that the effector-phase suppressor cells described in the present report have the same properties (idiotype binding, effector phase, Igh restricted, Lyt-2 bearing) as the effector-phase suppressor T cells, which suppress DTH and contact sensitivity responses (6, 24, 26) . Thus, it appears that the same suppressor cell populations are able to regulate both T cell and B cell responses.
Summary
The ability of T suppressor cells, induced by the intravenous injection of 4-hydroxy-3-nitrophenyl acetyl (NP)-modified syngeneic spleen cells, to affect an ongoing B cell response was studied in vitro. It was found that the expression of NP u idiotype-positive B cells could be selectively inhibited by the addition of antigen-induced suppressor cells in the last 24 h of the in vitro culture. This effector-phase suppression of B cell responses was antigen specific and mediated by an Lyt 1-, Lyt 2 +, idiotype-binding, T cell population whose suppressive function was restricted by genes linked to the Igh lOCUS.
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